ACADIA Pharmaceuticals Inc (ACAD)

Fixed asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 957,797 929,236 890,534 813,806 726,437 631,886 550,901 520,229 517,235 511,503 512,401 493,059 484,145 474,394 463,359 458,241 441,755 419,074 393,083 366,185
Property, plant and equipment US$ in thousands — — — — — 55,642 — 5,595 61,594 6,510 64,433 7,531 66,315 8,581 70,568 72,868 9,161 8,427 6,687 5,089
Fixed asset turnover — — — — — 11.36 — 92.98 8.40 78.57 7.95 65.47 7.30 55.28 6.57 6.29 48.22 49.73 58.78 71.96

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $957,797K ÷ $—K
= —

The fixed asset turnover ratio for ACADIA Pharmaceuticals Inc has shown some fluctuations over the periods provided.

- From March 31, 2020, to September 30, 2021, the fixed asset turnover ratio was relatively high, indicating that the company was able to generate a significant amount of revenue relative to its investment in fixed assets.
- However, the ratio significantly dropped in the subsequent periods, reaching as low as 6.29 on March 31, 2021, and 6.57 on June 30, 2021, which may suggest a decrease in efficiency in utilizing its fixed assets to generate sales.
- The ratio then fluctuated, reaching 92.98 on March 31, 2023, indicating a substantial improvement in asset utilization efficiency before dropping again in the following periods.
- There are some missing data points, particularly in the latter half of 2023 and all quarters of 2024, making it challenging to provide a complete trend analysis.

Overall, fluctuations in the fixed asset turnover ratio for ACADIA Pharmaceuticals Inc indicate varying levels of efficiency in utilizing its fixed assets to generate revenue over the periods provided. Further analysis combining this ratio with other financial metrics would provide a more comprehensive understanding of the company's operational efficiency and asset management.